Fundraising FoxExSight Ventures
Venture capitalNew York · Pre-Seed–Series B · 4 people tracked
Also known as ExSight
Find your way into ExSight Ventures
277 people in our graph share verified history with the ExSight Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
ExSight Ventures invests in early-stage companies developing breakthrough technologies to aid, diagnose, and treat people affected by vision diseases. The firm leverages deep ophthalmology domain expertise—led by two retinal surgeons—as an advantage over generalist investors, treating its focused specialization as a form of validation for a company's technology. It emphasizes capital efficiency, investing predominantly in technology development at the pre-seed through Series B stages. The firm argues that diversification is best achieved across focused managers rather than across holdings, and points to macro trends such as an aging population, rising diabetes, and a growing global middle class as drivers of demand for eye care innovation.
Source: firm website, verified Aug 3, 2026.
Team · 4 people
from the firm's websiteWhat they invest in
from 17 of 24 portfolio companiesBiotech ×11Healthtech ×9Medical Devices ×7AI & Machine Learning ×4Data & Infrastructure ×2Media & Entertainment ×2Advanced Manufacturing ×1Consumer ×1
HQs:United States×10United Kingdom×1Japan×1
Investments · 24 tracked
founders shown can be your intro pathBy year:2025 · 12023 · 22022 · 32020 · 22019 · 22017 · 111 dated
ONL Therapeutics is a clinical-stage biopharmaceutical company developing therapies to preserve sight by preventing Fas-mediated death of retinal cells, a cause of vision loss and blindness.
BiotechHealthtechMedical DevicesAnn Arbor, US
David Zacks(Co-Founder & Chief Scientific Officer)inDavid Esposito(Executive Officer, Director)inConstance Chang(Executive Officer)John K Freshley(Executive Officer, Director)inJeffrey A Jamison(Executive Officer)in
BoardAaron Fletcher(Director)in
Co-investorsInvest MichiganNovartis Venture FundVisionary VenturesBios PartnersInFocus Capital Partners, LLCJohnson & Johnson Innovation – JJDC+3 more
Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.
BiotechHealthtechMedical DevicesSan Diego, US
David Eveleth(Executive Officer, Director)inSchalon Newton(Executive Officer)in
BoardChristy Shaffer(Director)inRalph Bradshaw(Director)
Co-investorsHatteras Venture PartnersSolasta VenturesAccess BiotechnologyBios PartnersCorrelation VenturesFemHealth Ventures+1 more
HealthtechIrvine, US
JAMES TAYLOR(Executive Officer)IRVING ROBERT ARMSTRONG(Executive Officer)ROBERT SHIMIZU(Executive Officer)NARESH MANDAVA(Director)
BoardAKITERU FURUKAWA(Director)CLAUDE BENEDICT(Director)
Co-investorsInFocus Capital Partners, LLC
The page presented is corporate content for Novartis, a pharmaceutical company that develops medicines across areas such as multiple sclerosis, cardiovascular disease, and oncology.
BiotechHealthtechSan Diego, US
Arthur T Suckow(Executive Officer)inArthur Suckow, Ph.D.(Founder)in
Co-investorsAccess BiotechnologyRA CapitalJanus Henderson Investors
Implant-free, minimally invasive glaucoma surgery (MIGS) creating microscopic channels in the eye to lower intraocular pressure.
A Japanese manufacturer and seller of billiard equipment, including cues, tips, and chalk, serving players and retailers worldwide through overseas distributors across 25+ countries.
Advanced ManufacturingConsumerHiroshima, JP
Masato Hiraoka(Chairman)Kazumi Kuwahara(President)
Co-investorsD CapitalGICNP-Hard Ventures
Horizon Surgical Systems develops surgical robotics for ophthalmic procedures, with a focus on improving cataract surgery.
AI & Machine LearningHealthtechMedical DevicesRobotics
Jacob Rosen(Founder)in
Springer is an academic and scientific publisher with a portfolio of over 2,700 journals and more than 220,000 books, serving researchers, authors, readers, and institutions worldwide.
Media & Entertainment
Co-investorsChanzo Capital
LensGen is an ophthalmic medical device company that has developed Juvene, a curvature-changing fluid-optic intraocular lens designed to treat cataracts and presbyopia.
BiotechHardwareHealthtechMedical DevicesIrvine, US
Ramgopal Rao(Founder & Chief Executive Officer)
BoardAkiteru Furukawa(Director)Michael Colaco(Director)Shivbir Grewal(Director)
Novai applies advanced molecular and computational approaches to eye disease, supporting clinicians and researchers in translating scientific findings into patient treatment options.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesReading, GB
Prof. Francesca Cordeiro(Founder, Director & Chief Executive Officer)Prof. M. Francesca Cordeiro(Founder & CEO)MARIA FRANCESCA CORDEIRO(Director)
BoardNATALIE PANKOVA(Director)inKARL DAVID KEEGAN(Director)STEPHEN ROY PAGE(Director)
Co-investorsAnglia Capital GroupInBC Investment Corp.Zinc
Constellation Pharmaceuticals was a Cambridge, MA clinical-stage biopharmaceutical company developing epigenetics-based cancer therapies, including BET and EZH2 inhibitors.
BiotechHealthtech
Co-investorsClal Biotechnology IndustriesLongitude CapitalTachyon VenturesThe Column Group
Valitor develops bioactive molecule therapies using a multivalent biopolymer technology platform to create long-acting treatments for ophthalmologic diseases, with its lead candidate VLTR-559 targeting wet age-related macular degeneration.
BiotechMedical DevicesBerkeley, US
Wesley Jackson(President, Chief Scientific Officer & Member of the Board)inGregory D. Kunst(Chief Executive Officer)Carole H Bellis(Executive Officer)Kevin E Healy(Director)Jackson M Wesley(Executive Officer, Director)
BoardDrew Lanza(Director)in
Co-investorsAngel Physicians FundBerkeley CatalystFirst Spark Ventures, LlcPandect Bioventures
Vana is an open data infrastructure platform that enables individuals to control and manage the data they generate, with the ability to choose how it is used by AI systems.
AI & Machine LearningData & Infrastructure
Art Abal(Founder)
Co-investorsAbstract VenturesAlphaLab CapitalCaladanEarl Grey CapitalParadigmSCB 10X+7 more
Vana provides open data infrastructure for AI that lets individuals control the data they create and choose how it is used.
AI & Machine LearningCrypto & Web3Data & Infrastructure
Co-investorsFlori VenturesBoxGroupCoinbase VenturesDeFiance CapitalGSRInFocus Capital Partners, LLC+7 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AjoEnvision DiagnosticsLwwQuraRe-vanaRe-Vana TherapeuticsRetroSense TherapeuticsRevOpsis Therapeutics
Exits · 3
3 acquisitionsDTx Pharmaacq. by NovartisRetroSense Therapeuticsacq. by AllerganThumbnail for Constellation Pharmaceuticalsacq. by Morphosys
Frequently asked questions
- How many investments has ExSight Ventures made?
- ExSight Ventures has 24 tracked investments, 3 of which have exited, including 1 dated in the last 24 months.
- What stage does ExSight Ventures invest at?
- ExSight Ventures invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does ExSight Ventures focus on?
- ExSight Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is ExSight Ventures located?
- ExSight Ventures is headquartered in New York.
- Who does ExSight Ventures co-invest with?
- ExSight Ventures most often shares deals with Visionary Ventures, First Spark Ventures, Llc, Lightstone Ventures, among 23 tracked co-investors.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.